The optimal role of remdesivir remains uncertain, and some guidelines panels (including the World Health Organization) suggest not using it in hospitalized patients because there is no clear evidence that it improves patient-important outcomes for hospitalized patients (eg, mortality, need for mechanical ventilation)
- Forums
- ASX - By Stock
- Ann: Veyonda Showing Potential to Prevent Cytokine Storm
The optimal role of remdesivir remains uncertain, and some...
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
8.2¢ |
Change
-0.005(5.75%) |
Mkt cap ! $23.96M |
Open | High | Low | Value | Volume |
8.7¢ | 8.7¢ | 8.1¢ | $50.65K | 608.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 131400 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.6¢ | 7168 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 131400 | 0.082 |
2 | 170000 | 0.081 |
2 | 200000 | 0.080 |
1 | 15000 | 0.078 |
1 | 14091 | 0.077 |
Price($) | Vol. | No. |
---|---|---|
0.086 | 7168 | 1 |
0.091 | 10989 | 1 |
0.093 | 37410 | 1 |
0.095 | 54200 | 2 |
0.096 | 35000 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |